Los Angeles Capital Management LLC bought a new position in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 1,774 shares of the biotechnology company's stock, valued at approximately $709,000.
Several other hedge funds also recently modified their holdings of AXON. Quent Capital LLC boosted its stake in shares of Axon Enterprise by 1,875.0% during the third quarter. Quent Capital LLC now owns 79 shares of the biotechnology company's stock valued at $32,000 after purchasing an additional 75 shares in the last quarter. Blue Trust Inc. increased its position in Axon Enterprise by 987.5% in the 2nd quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company's stock valued at $27,000 after acquiring an additional 79 shares during the period. Friedenthal Financial acquired a new position in shares of Axon Enterprise during the third quarter worth $51,000. Reston Wealth Management LLC acquired a new position in shares of Axon Enterprise during the third quarter worth $60,000. Finally, Asset Dedication LLC bought a new stake in shares of Axon Enterprise in the second quarter worth $47,000. Institutional investors and hedge funds own 79.08% of the company's stock.
AXON has been the subject of several recent research reports. Northland Securities increased their price target on Axon Enterprise from $365.00 to $550.00 and gave the company an "outperform" rating in a research note on Monday, November 11th. JMP Securities upped their price objective on shares of Axon Enterprise from $430.00 to $500.00 and gave the company a "market outperform" rating in a research note on Thursday, October 31st. Barclays lifted their target price on shares of Axon Enterprise from $381.00 to $387.00 and gave the stock an "overweight" rating in a research note on Wednesday, August 7th. Needham & Company LLC increased their price target on Axon Enterprise from $525.00 to $600.00 and gave the stock a "buy" rating in a report on Friday, November 8th. Finally, The Goldman Sachs Group boosted their price objective on Axon Enterprise from $385.00 to $441.00 and gave the company a "buy" rating in a research note on Wednesday, October 23rd. Two equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. Based on data from MarketBeat, Axon Enterprise presently has a consensus rating of "Moderate Buy" and a consensus price target of $427.83.
Check Out Our Latest Stock Analysis on Axon Enterprise
In related news, CFO Brittany Bagley sold 4,338 shares of the business's stock in a transaction dated Thursday, September 12th. The shares were sold at an average price of $378.95, for a total transaction of $1,643,885.10. Following the transaction, the chief financial officer now directly owns 98,825 shares in the company, valued at approximately $37,449,733.75. The trade was a 4.20 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Julie A. Cullivan sold 900 shares of the company's stock in a transaction dated Thursday, September 5th. The stock was sold at an average price of $353.53, for a total transaction of $318,177.00. Following the completion of the sale, the director now directly owns 3,653 shares of the company's stock, valued at $1,291,445.09. The trade was a 19.77 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 411,006 shares of company stock valued at $161,360,618 over the last 90 days. Insiders own 6.10% of the company's stock.
AXON stock opened at $599.35 on Friday. The company has a market capitalization of $45.70 billion, a P/E ratio of 154.87, a price-to-earnings-growth ratio of 15.10 and a beta of 0.94. Axon Enterprise, Inc. has a 52-week low of $220.78 and a 52-week high of $624.84. The business has a 50-day simple moving average of $438.79 and a two-hundred day simple moving average of $357.27. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96.
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Axon Enterprise, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.
While Axon Enterprise currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.